Opus Regulatory Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Opus Regulatory's estimated annual revenue is currently $23.1M per year.(i)
  • Opus Regulatory's estimated revenue per employee is $201,000

Employee Data

  • Opus Regulatory has 115 Employees.(i)
  • Opus Regulatory grew their employee count by 8% last year.

Opus Regulatory's People

NameTitleEmail/Phone
1
Director Finance & ControllerReveal Email/Phone
2
Employee Experience ManagerReveal Email/Phone
3
Senior Contracts ManagerReveal Email/Phone
4
Operations ManagerReveal Email/Phone
5
Principal ConsultantReveal Email/Phone
6
Principal Consultant, Regulatory AffairsReveal Email/Phone
7
Principal Consultant, Regulatory AffairsReveal Email/Phone
8
Principal Consultant Regulatory Affairs Opus RegulatoryReveal Email/Phone
9
Principal Consultant, Regulatory Affairs LabelingReveal Email/Phone
10
Practice Lead Regulatory Strategy and CMCReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is Opus Regulatory?

Founded in 1994, Opus Regulatory is a leading regulatory affairs contract consulting firm serving biopharmaceutical companies throughout the US. We leverage a highly focused operating model designed to deliver a superior, cost effective solution for our clients'​ RA project needs. We combine RA functional expertise, a network of thousands of regulatory professionals and 20 years'​ experience to deliver these services. RA functional areas include Regulatory Strategy, Labeling and Advertising & Promotion.

keywords:N/A

N/A

Total Funding

115

Number of Employees

$23.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Opus Regulatory News

2022-04-17 - Collective Wealth Of Korea's 50 Richest On 2022 Forbes List ...

... Covid-19 antibody treatment has yet to secure U.S. regulatory approval. ... through a business combination with Magnum Opus (NYSE: OPA),...

2022-04-13 - Redeployment of odontode gene regulatory network underlies ...

Redeployment of odontode gene regulatory network underlies dermal denticle ... for RfxCas13d protein production (Bon Opus Biosciences, LLC).

2022-04-06 - TraceLink Launches its Opus Compliance Framework with the ...

... which compliance report, when to send it, and how to send it to the regulatory authority. The Opus platform and its "Integrate Once,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M11513%$13.2M
#2
$20.7M11520%N/A
#3
$18M1164%N/A
#4
$15M11633%N/A
#5
$11.8M1162%N/A